Kewaunee Scientific Co. (NASDAQ:KEQU) Director Buys $35,000.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) Director Keith M. Gehl acquired 1,000 shares of the firm’s stock in a transaction on Friday, April 4th. The stock was bought at an average price of $35.00 per share, with a total value of $35,000.00. Following the purchase, the director now directly owns 18,500 shares of the company’s stock, valued at $647,500. This represents a 5.71 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Kewaunee Scientific Stock Up 9.6 %

Shares of Kewaunee Scientific stock opened at $38.31 on Thursday. The company has a fifty day moving average price of $50.85 and a 200 day moving average price of $47.35. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a twelve month low of $30.82 and a twelve month high of $71.33. The stock has a market cap of $109.38 million, a price-to-earnings ratio of 6.07 and a beta of 0.59.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The firm had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Bank of America Corp DE grew its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after purchasing an additional 443 shares during the last quarter. IFP Advisors Inc bought a new position in Kewaunee Scientific in the 4th quarter worth about $36,000. JPMorgan Chase & Co. grew its position in Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the last quarter. Morgan Dempsey Capital Management LLC bought a new position in Kewaunee Scientific in the 4th quarter worth about $106,000. Finally, Barclays PLC bought a new position in Kewaunee Scientific in the 3rd quarter worth about $121,000. Institutional investors own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.